Log In
BCIQ
Print this Print this
 

Adrenergic receptor alpha (ADRA)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Adrenergic receptor alpha (ADRA)

BCIQ
Print ChartPrint this
1 - Neurology 1 - Genitourinary 3 - Cardiovascular 1 - Cardiovascular 1 - Neurology 1 - Genitourinary 1 - Gastrointestinal
Phase of DevelopmentPhase IIApprovedMarketed
Cardiovascular

-

1

3

Gastrointestinal

1

-

-

Genitourinary

1

-

1

Neurology

1

-

1




 Products Targeting Adrenergic receptor alpha (ADRA)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$160,789.0M

$160,075.0M

$200.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today